The pain management and devices used for pain management and inflammation management market has crossed a worldwide level of $42 billion and by 2023 it is estimated to cross the landmark of $ 72 billion market size. Various medications and treatments are being considered in order to treat the pain and in the management of the pain world over. However, a breakthrough medicine and treatment is still awaited in the medical science. One such lead medicine which can become a breakthrough treatment option for pain and inflammation management is the enzyme and drug serratiopeptidase. Serratiopeptidase is a proteolytic enzyme extracted from species, Bombyx mori. The present letter is an effort to draw attention of scientists and researchers towards this wonder pain relief enzyme, serratiopeptidase.
Loading....